Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs

Overview of attention for article published in Arthritis Research & Therapy, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 133 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Effects of tofacitinib monotherapy on patient-reported outcomes in a randomized phase 3 study of patients with active rheumatoid arthritis and inadequate responses to DMARDs

Bioportfolio, 05 Nov 2015

IntroductionTofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.MethodIn this 6-month…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.